Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial.
Leong DP, Cosman T, Alhussein MM, Kumar Tyagi N, Karampatos S, Barron CC, Wright D, Tandon V, Magloire P, Joseph P, Conen D, Devereaux PJ, Ellis PM, Mukherjee SD, Dhesy-Thind S.
Leong DP, et al. Among authors: alhussein mm.
JACC CardioOncol. 2019 Jul 17;1(1):1-10. doi: 10.1016/j.jaccao.2019.06.004. eCollection 2019 Sep.
JACC CardioOncol. 2019.
PMID: 34396157
Free PMC article.